Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TA 8995 in patients with mild dyslipidaemia, alone and in combination with statin therapy
2012-005643-24Phase 2Completed
- Sponsor
- Xention Ltd.
- Start
- Jun 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of obicetrapib in lipid disorder, hypercholesterolemia, sponsored by Xention Ltd.. Started Jun 2013; status: completed.
02
Drugs
obicetrapib
03
Conditions
lipid disorderhypercholesterolemia
Beyond the preview
Go deeper on 2012-005643-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005643-24.